Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Teck Lim

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion StudyLucia Nogova, Lecia V Sequist, Jose Manuel Perez Garcia, et al.
JCO Precision Oncology|October 14, 2022
Clinical and Genomic Features of <i>HER2</i> Exon 20 Insertion Mutations and Characterization of <i>HER2</i> Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung CancerAaron C Tan, Stephanie P L Saw, Jianbin Chen, et al.
Cancer|February 29, 2024
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancerAaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, et al.
Nature Communications|June 22, 2016
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progressionWen Cai Zhang, Tan Min Chin, Henry Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Nature Medicine|May 23, 2019
Publisher Correction: Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
Nature Medicine|May 8, 2019
Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
Frontiers in Oncology|August 2, 2021
Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast CancerSay Li Kong, Xingliang Liu, Swee Jin Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Plos One|May 9, 2015
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAmit Jain, Cindy Lim, Eugene MingJin Gan, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion StudyLucia Nogova, Lecia V Sequist, Jose Manuel Perez Garcia, et al.
JCO Precision Oncology|October 14, 2022
Clinical and Genomic Features of <i>HER2</i> Exon 20 Insertion Mutations and Characterization of <i>HER2</i> Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung CancerAaron C Tan, Stephanie P L Saw, Jianbin Chen, et al.
Cancer|February 29, 2024
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancerAaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, et al.
Nature Communications|June 22, 2016
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progressionWen Cai Zhang, Tan Min Chin, Henry Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Nature Medicine|May 23, 2019
Publisher Correction: Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
Nature Medicine|May 8, 2019
Methionine is a metabolic dependency of tumor-initiating cellsZhenxun Wang, Lian Yee Yip, Jia Hui Jane Lee, et al.
Frontiers in Oncology|August 2, 2021
Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast CancerSay Li Kong, Xingliang Liu, Swee Jin Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Plos One|May 9, 2015
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAmit Jain, Cindy Lim, Eugene MingJin Gan, et al.
Pageof 14